novo direct semaglutide Canada approves generic from Dr. Reddy's, a G7 first enabled by Nordisk's lapsed CAD$250 patent Novo Nordisk to sell obesity

No Digital Authentication Option Some advanced packaging now lets you check a products authenticity with your smartphone

Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications

Additionally, GLP-1 medications slow gastric emptying , which helps moderate the post-meal rise in blood glucose and promotes satiety

Improper mixing can lead to several catastrophic failures

miRNA-223 expression in patient-derived eutopic and ectopic endometrial stromal cells and its effect on epithelial-to-mesenchymal transition in endometriosis

Significant weight changes while on GLP-1 agonists should prompt a full medication review